Related Experiment Video
Updated: Aug 12, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Approaches to Treating Kratom Use Disorder in the Perinatal Population
James Hardy1, Amy Marietta1, Nathan Mullins1
1Mountain Area Health Education Center, Asheville, North Carolina.
Kratom use disorder (KUD) in pregnancy presents unique challenges due to unregulated products and potential withdrawal for mother and infant. This case study explores buprenorphine treatment strategies for perinatal KUD.
Area of Science:
- Pharmacology
- Substance Use Disorders
- Maternal-Fetal Medicine
Background:
- Kratom is increasingly used for pain and opioid withdrawal, despite being unregulated and posing risks of substance use disorder.
- Perinatal kratom use disorder (KUD) carries risks of maternal and infant withdrawal, with limited research on effective management.
- Misperceptions of kratom's safety and limited screening tools complicate KUD diagnosis and treatment.
Related Concept Videos
Factors Affecting Drug Response: Overview
Drug Abuse and Addiction: Pharmacological Phenomena
Pharmaceutical Poisoning: Treatment Strategies
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Antidepressant Drugs: MAOIs and Other Agents
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
